The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Thrombocytosis (High Platelets)

Causes of elevated platelet counts and management of associated thrombotic risk.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Thrombocytosis (High Platelets)?

Thrombocytosis is defined as a sustained platelet count greater than 450,000/microliter (the upper limit of normal). It is broadly classified into two categories: reactive (secondary) thrombocytosis, which represents a response to an underlying condition, and clonal thrombocytosis, which arises from a primary bone marrow disorder.

Reactive thrombocytosis is the more common form (over 80% of cases) and occurs in response to infection, inflammation, iron deficiency, hemorrhage, surgery, malignancy, or splenectomy. The platelet count typically returns to normal once the underlying cause is treated. Reactive thrombocytosis rarely causes thrombosis even at high platelet counts.

Clonal thrombocytosis results from myeloproliferative neoplasms, most notably essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis. JAK2, CALR, and MPL mutations are commonly identified. Unlike reactive thrombocytosis, clonal thrombocytosis carries significant risk of thrombotic and hemorrhagic complications and may transform into acute leukemia or myelofibrosis.

Symptoms

Often asymptomatic, discovered on routine blood test
Headache, dizziness, visual disturbances
Erythromelalgia (burning pain, redness in extremities)
Numbness or tingling in fingers/toes
Easy bruising or bleeding (paradoxical at very high platelet counts)
Thrombotic events: stroke, MI, DVT, pulmonary embolism
Splenomegaly (in myeloproliferative disorders)
Symptoms of underlying cause in reactive thrombocytosis

Risk Factors

Acute or chronic infection (most common reactive cause)
Iron deficiency anemia
Recent surgery, trauma, or hemorrhage
Inflammatory conditions (rheumatoid arthritis, IBD, vasculitis)
Malignancy (lung, GI, breast cancers)
Post-splenectomy state (lifelong elevation)
Family history of myeloproliferative disorders
JAK2, CALR, MPL mutations (clonal thrombocytosis)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent platelet count above 450,000/μL on multiple checks
  • Platelet count above 1,000,000/μL (extreme thrombocytosis)
  • Symptoms suggesting thrombosis (chest pain, stroke symptoms, leg swelling)
  • Microvascular symptoms (headache, visual changes, erythromelalgia)
  • Bleeding symptoms with high platelets (acquired von Willebrand)
  • Splenomegaly or constitutional symptoms
  • No obvious reactive cause identified
  • Family history of myeloproliferative neoplasm

Treatment Methods

01
Treat underlying cause for reactive thrombocytosis (no platelet-directed therapy needed)
02
Iron repletion: for iron deficiency anemia driving reactive thrombocytosis
03
Risk stratification for clonal thrombocytosis: age, prior thrombosis, JAK2 status
04
Low-dose aspirin: for symptomatic microvascular events or low/intermediate risk
05
Cytoreductive therapy: hydroxyurea (first-line) for high-risk essential thrombocythemia
06
Anagrelide: alternative for hydroxyurea-intolerant patients
07
Interferon alpha (pegylated): in younger patients or pregnancy
08
Bone marrow biopsy and molecular testing: confirm diagnosis if clonal disorder suspected

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.